The Legal Examiner Affiliate Network The Legal Examiner The Legal Examiner The Legal Examiner search instagram avvo phone envelope checkmark mail-reply spinner error close The Legal Examiner The Legal Examiner The Legal Examiner
Skip to main content

In the wake of Depuy Acetabular System and DePuy ASR Hip Resurfacing System being recalled, the

U.S. Food and Drug Administration is taking a close look at all-metal replacement hip implants, which have faced sales pressure amid concerns about metal particles wearing off and causing medical problems.

According to the Wall Street Journal

[t]he FDA on Thursday launched a detailed page covering these metal-on-metal implants on its website. The agency said it’s "actively working in several areas to further assess the safety and effectiveness" of the devices, which have metal surfaces on both the ball and socket portions. Manufacturers include Johnson & Johnson’s (JNJ) DePuy unit and privately held Biomet Inc.

As many of our readers are aware, on August 26, 2010, DePuy Orthopaedics, a division of Johnson & Johnson, issued a voluntary recall of two of their hip replacement systems, the ASR™ XL Acetabular System and DePuy ASR Hip Resurfacing System. Studies found that many patients who received these DePuy hip implants suffer from symptoms including pain, swelling and difficulty walking, and have to undergo a revision surgery to correct painful issues with the implants.

The Oklahoma Depuy Hip lawyers at McIntyre Law encourages all those who may have received DePuy ASR Hip Resurfacing System or an ASR XL Acetabular System to protect their legal rights by contacting a DePuy recall lawyer.

One Comment

  1. Gravatar for Kevin Duffan
    Kevin Duffan

    The worst part is that after going through the painful surgery and recovery, patients who received the Depuy hip replacement may have to do it all over again as the failure rate is about twice the medical device industry average. This means they will be forced to endure an additional, expensive hip replacement surgery.

Comments for this article are closed.